Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia

Journal of Hypertension

Volumn 29, Issue 11, 2011, Pages 2210-2219

  Fu, Hua ^a   Hosomi, Naohisa ^a,b   Pelisch, Nicolas ^a   Nakano, Daisuke ^a   Liu, Gang ^a   Ueno, Masaki ^a   Miki, Takanori ^a   Masugata, Hisashi ^a   Sueda, Yoshimasa ^b   Itano, Toshifumi ^a   Matsumoto, Masayasu ^b   Nishiyama, Akira ^a   Kohno, Masakazu ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

angiotensin II; candesartan; cerebral edema; cerebral ischemia; therapeutic time window

Indexed keywords

ANGIOTENSIN II; CANDESARTAN; HALOTHANE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG MEGADOSE; HYPOTENSION; LOW DRUG DOSE; MALE; MIDDLE CEREBRAL ARTERY; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY;

EID: 80054110392     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834bbb30     Document Type: Article

References (33)

1. Hosomi N, Mizushige K, Kitadai M, Ohyama H, Ichihara SI, Takahashi T, Matsuo H. Induced hypertension treatment to improve cerebral ischemic injury after transient forebrain ischemia. Brain Res 1999; 835:188-196. (Pubitemid 29343780)
2. Wahlgren NG, MacMahon DG, De Keyser J, Indredavik B, Ryman T. Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis 1994; 4:204-210.
3. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002; 33:1315-1320. (Pubitemid 34517053)
4. Schrader J, Lü ders S, Kulschewski A, Berger J, Zidek W, Treib J, et al. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003; 34:1699-1703. (Pubitemid 36842630)
5. Nakamura T, Tsutsumi Y, Shimizu Y, Uchiyama S. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase. J Stroke Cerebrovasc Dis 2010; 19:435-440.
6. Sandset EC, Bath PM, Boysen G, Jatuzis D, Korv J, Luders S, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011; 377:741-750.
7. Pelisch N, Hosomi N, Ueno M, Masugata H, Murao K, Hitomi H, et al. Systemic candesartan reduces brain angiotensin II via downregulation of brain renin-angiotensin system. Hypertens Res 2010; 33:161-164.
8. Hosomi N, Nishiyama A, Ban CR, Naya T, Takahashi T, Kohno M, Koziol JA. Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia. Neuroscience 2005; 134:225-231. (Pubitemid 40943649)
9. Werner C, Hoffman WE, Kochs E, Rabito SF, Miletich DJ. Captopril improves neurologic outcome from incomplete cerebral ischemia in rats. Stroke 1991; 22:910-914.
10. Nishimura Y, Ito T, Saavedra JM. Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 2000; 31:2478-2486.
11. Brdon J, Kaiser S, Hagemann F, Zhao Y, Culman J, Gohlke P. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke. J Hypertens 2007; 25:187-196. (Pubitemid 44885681)
12. Omura-Matsuoka E, Yagita Y, Sasaki T, Terasaki Y, Oyama N, Sugiyama Y, et al. Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats. Hypertens Res 2009; 32:548-553.
13. Zea-Longa E, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20:84-91. (Pubitemid 19040218)
14. Hosomi N, Ban CR, Naya T, Takahashi T, Guo P, Song XY, Kohno M. Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2005; 25:959-967. (Pubitemid 41061711)
15. Lin TN, He YY, Wu G, Khan M, Hsu CY. Effect of brain edema on infarct volumein a focal cerebral ischemiamodel in rats. Stroke 1993; 24:117-121. (Pubitemid 23014393)
16. Louin G, Marchand-Verrecchia C, Palmier B, Plotkine M, Jafarian-Tehrani M. Selective inhibition of inducible nitric oxide synthase reduces neurological deficit but not cerebral edema following traumatic brain injury. Neuropharmacology 2006; 50:182-190. (Pubitemid 43100004)
17. Fox J, Guan S, Hymel AA, Navar LG. Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats. Am J Physiol 1992; 262:F902-F909.
18. Nagai Y, Miyata K, Sun GP, Rahman M, Kimura S, Miyatake A, et al. Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension 2005; 46:1039-1045.
19. Zausinger S, Hungerhuber E, Baethmann A, Reulen H, Schmid-Elsaesser R. Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms. Brain Res 2000; 863:94-105. (Pubitemid 30201588)
20. Miyata K, Rahman M, Shokoji T, Nagai Y, Zhang GX, Sun GP, et al. Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells. J Am Soc Nephrol 2005; 16:2906-2912. (Pubitemid 44743488)
21. Perich R, Jackson B, Paxton D, Johnston CI. Characterization of angiotensin converting enzyme in isolated cerebral microvessels from spontaneously hypertensive and normotensive rats. J Hypertens 1992; 10:149-153.
22. Stenman E, Edvinsson L. Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats. Stroke 2004; 35:970-974. (Pubitemid 38419812)
23. Stenman E, Jamali R, Henriksson M, Maddahi A, Edvinsson L. Cooperative effect of angiotensin AT(1) and endothelin ET(A) receptor antagonism limits the brain damage after ischemic stroke in rat. Eur J Pharmacol 2007; 570:142-148. (Pubitemid 47248667)
24. Kozak W, Kozak A, Johnson MH, Elewa HF, Fagan SC. Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response study. J Pharmacol Exp Ther 2008; 326:773-782.
25. Schmerbach K, Schefe JH, Krikov M, Muller S, Villringer A, Kintscher U, et al. Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain. Brain Res 2008; 1208:225-233.
26. Kozak A, Ergul A, El-RemessyAB, JohnsonMH,MachadoLS, ElewaHF, et al. Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke. Stroke 2009; 40:1870-1876.
27. Engelhorn T, Goerike S, Doerfler A, Okorn C, Forsting M, Heusch G, Schulz R. The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats. J Cereb Blood Flow Metab 2004; 24:467-474. (Pubitemid 38455442)
28. Engelhorn T, Doerfler A, Heusch G, Schulz R. Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination: an experimental study in rats. Neurosci Lett 2006; 406:92-96. (Pubitemid 44278379)
29. Inaba S, Iwai M, Tomono Y, Senba I, Furuno M, Kanno H, et al. Exaggeration of focal cerebral ischemia in transgenic mice carrying human Renin and human angiotensinogen genes. Stroke 2009; 40:597-603.
30. Chen S, Li G, Zhang W, Wang J, Sigmund CD, Olson JE, Chen Y. Ischemia-induced brain damage is enhanced in human renin and angiotensinogen double-transgenic mice. Am J Physiol Regul Integr Comp Physiol 2009; 297:R1526-R1531.
31. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002; 109:1417-1427. (Pubitemid 34596167)
32. Shan Z, Cuadra AE, Sumners C, Raizada MK. Characterization of a functional (pro)renin receptor in rat brain neurons. Exp Physiol 2008; 93:701-708. (Pubitemid 351595061)
33. Schmerbach K, Pfab T, Zhao Y, Culman J, Mueller S, Villringer A, et al. Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes. PLoS One 2010; 5:e15052.